PH
PharmaMar
PHM.MC·BMEMadrid ESFounded 1986500 employees
Small CappharmaPublicOncology
Platform: Zepzelca Lurbi
Market Cap
$1.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (PHM.MC)
Loading PHM.MC stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PHM-5291 | PHM-5291 | Phase 3 | 1 | BCMA | GISTRett | ||
| Elracapivasertib | PHM-9578 | Approved | 2 | PD-L1 | Atopic DermHNSCC |
SEC Filings & Financial Documents
SEC filings are not available for BME-listed companies.
PharmaMar trades on BME (ES). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)